Unusual responses to PCSK9 inhibitors in a clinical cohort utilizing a structured follow-up protocol

Authors:

Abstract
No abstract available
Funding Information
  • National Institutes of Health (K12HD043488, RO1 5R01HL132985, RO1 P30DK36836)

This publication has 27 references indexed in Scilit: